Страна: Австралия
Език: английски
Източник: APVMA (Australian Pesticides and Veterinary Medicines Authority)
DETOMIDINE HYDROCHLORIDE
JUROX PTY LIMITED
detomidine HCl(7.6mg/mL)
ORAL GEL
DETOMIDINE HYDROCHLORIDE IMIDAZOLE Active 7.6 mg/ml
3mL
VM - Veterinary Medicine
JUROX
HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL
ANAESTHETICS/ANALGESICS
RESTRAINT | SEDATIVE | SEDATIVE
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: HORSE: [RESTRAINT, SEDATIVE]; Oromucosal gel for sublingual use. For sedation and restraint in horses.NOT TO BE USED in food producing animals. See label.
Registered
2023-07-01
REGISTRANT: Pfizer Animal Health TRADE NAME: DORMOSEDAN ® Gel APVMA NO.: 65579 PREPARATION DATE: 06 December 2012 PAGE: 1 of 9 COMMENTS: Various changes to content as per APVMA requirements letter dated 30 November 2012. Text in the header box will not appear on the final label LABEL RIGHT PANEL PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN READ SAFETY DIRECTIONS BEFORE OPENING OR USING FOR ANIMAL TREATMENT ONLY [Horse graphic] DORMOSEDAN ® GEL 3.0 ML 7.6 MG/ML DETOMIDINE HYDROCHLORIDE Oromucosal gel for sublingual use. For sedation and restraint in horses [Pfizer Logo] LABEL CENTER PANEL READ ENCLOSED LEAFLET BEFORE USING THIS PRODUCT RESTRAINT: NOT TO BE USED IN FOOD PRODUCING ANIMALS Dose: Refer to enclosed leaflet MEAT WITHHOLDING PERIOD (HORSES): NOT TO BE USED IN HORSES INTENDED FOR HUMAN CONSUMPTION. APVMA No. 65579/51349 Developed and Manufactured by [Orion Pharma logo] Orion Corporation Espoo, Finland Store below 25°C (Air Conditioning) in original packaging. Protect from light. [Label identifier] LABEL LEFT PANEL Batch No Exp:.: RLP APPROVED REGISTRANT: Pfizer Animal Health TRADE NAME: DORMOSEDAN ® Gel APVMA NO.: 65579 PREPARATION DATE: 06 December 2012 PAGE: 2 of 9 COMMENTS: Various changes to content as per APVMA requirements letter dated 30 November 2012. Text in the header box will not appear on the final label CARTON MAIN PANEL PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN READ SAFETY DIRECTIONS BEFORE OPENING OR USING FOR ANIMAL TREATMENT ONLY [Horse graphic] DORMOSEDAN ® GEL 7.6 MG/ML DETOMIDINE HYDROCHLORIDE For sedation and restraint in horses 3.0 ML Oromucosal gel for sublingual use. [Pfizer Logo] CARTON REAR PANEL READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT DIRECTIONS FOR USE: RESTRAINT: NOT TO BE USED IN FOOD PRODUCING ANIMALS DOSAGE: This is a single-use product. Discard any remaining product after administration. APPROXIMATE BODY WEIGHT (KG) DOSE VOLUME (ML) RANGE OF DOSES (MG/KG) 150 – 199 1.00 0.051 – 0.038 200 – 249 1.25 0.047 – 0.038 250 – 2 Прочетете целия документ
PRODUCT NAME: DORMOSEDAN GEL PAGE: 1 OF 5 THIS VERSION ISSUED: NOVEMBER, 2015 SAFETY DATA SHEET Issued by: Zoetis Australia Pty Ltd Phone: 1800 814 883 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER ZOETIS AUSTRALIA PTY LTD ABN 94 156 476 425 Level 6, 5 Rider Blvd Rhodes NSW 2138 AUSTRALIA Tel: 1800 814 883 Fax: (02) 8876 0444 Email: australia.animalhealth@zoetis.com CHEMICAL NATURE: Detomidine is an imidazole derivative; an alpha-2-adrenergic receptor agonist. TRADE NAME: DORMOSEDAN GEL APVMA CODE: 65579 PRODUCT USE: Veterinary product used as analgesic, sedative. For veterinary use only as described on the product label. CREATION DATE: JUNE, 2013 THIS VERSION ISSUED: NOVEMBER, 2015 and is valid until June, 2018. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S23, S36, S24/25. Do not breathe vapours. Wear suitable protective clothing. Avoid contact with skin and eyes. SUSMP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated GHS SIGNAL WORD: NONE. NOT HAZARDOUS. HAZARD STATEMENT: PREVENTION P102: Keep out of reach of children. RESPONSE P353: Rinse skin or shower with water. P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. P332+P313: If skin irritation occurs: Get medical advice. P337+P313: If eye irritation persists: Get medical advice. P370+P378: Not combustible. Use extinguishing media suited to burning materials. STORAGE P402+P404: Store in a dry place. Store in a closed container. P403+P235: Store in a well-ventilated place. Keep cool. DISPOSAL P501: Dispose of small quantities and empty containers by wrapping with paper and putting in garbage. For larger quantities, if re Прочетете целия документ
WWW.JUROX.COM.AU Customer Service 1800 023 312 Dormosedan is a registered trademark of Orion Corporation TECHNICAL NOTES REGISTERED NAME Dormosedan® Gel ACTIVE CONSTITUENTS 7.6 mg/mL detomidine hydrochloride DESCRIPTION DORMOSEDAN Gel is an even, translucent blue gel containing 7.6 mg/mL detomidine hydrochloride. INDICATIONS DORMOSEDAN Gel is indicated for sedation and restraint in horses, appropriate for procedures such as grooming, hoof care, rasping of teeth, passage of nasogastric tube, endoscopy of the upper airway, oesophagus or stomach, or radiography. PHARMACOKINETICS Detomidine is an alpha-2 adrenoceptor agonist with a central effect inhibiting the transmission of noradrenalin-mediated nervous impulses. In the animal, the level of consciousness is lowered and the pain threshold is increased. The duration and level of sedation are dose dependent. In the studies conducted with the recommended 40 μg/kg dose of the gel, the time to onset of sedation has been approximately 30-40 minutes and the duration of sedation 1.5 to 3 hours. With detomidine administration, heart rate is decreased. A transient change in the conductivity of the cardiac muscle may occur, as evidenced by partial atrioventricular (AV) and sinoauricular (SA) blocks. Respiratory rate is slightly decreased. In some horses, sweating, salivation and slight muscle tremors may be seen. Partial, transient penis prolapse may occur in stallions and geldings. Blood glucose concentration may be temporally increased. DORMOSEDAN ® Gel WWW.JUROX.COM.AU Customer Service 1800 023 312 Dormosedan is a registered trademark of Orion Corporation TECHNICAL NOTES PHARMACODYNAMICS At a dose of 40 μg/kg, the mean C max for the sublingual product was 4.3 ng/mL. Although the t max was 1.83 hours for the sublingual product, clinical signs of sedation were evident at approximately half an hour after dosing. The bioavailability of sublingually administered detomidine gel in the horse is about 27%. If the product is swallowed the bioavailability is significantly decrea Прочетете целия документ